Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Plos One
|
October 24, 2025
Addressing multicollinearity in general linear model: A novel approach for ridge parameter with performance comparison
Muhammad Luqman, Sajjad Haider Bhatti, Demet Aydin, et al.
Scientific Reports
|
June 22, 2026
Hybrid analysis of photovoltaic energy data containing excessive structural zeros
Yasin Altinişik, Demet Aydin, Vedat Esen, et al.
Ocular Immunology and Inflammation
|
April 11, 2022
Orbital Mass as the Only Presenting Sign with Overlapping Features of Lupus Erythematosus Panniculitis and Subcutaneous Panniculitis-Like T-Cell Lymphoma
Mehmet Serhat Mangan, Ahmet Murat Sarici, Ozben Yalcin, et al.
Therapeutics and Clinical Risk Management
|
September 27, 2014
Bloodstream infections in patients with hematological malignancies: which is more fatal - cancer or resistant pathogens?
Habip Gedik, Funda Simşek, Arzu Kantürk, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|
May 2, 2022
Eltrombopag in the Treatment of Immune Thrombocytopenia: Two-Center Experience from Istanbul
Esma Evrim Dogan, Esra Turan Erkek, Tugrul Elverdi, et al.
Medicine
|
July 26, 2024
The assessment of health-related quality of life in patients with polycythemia vera
Esma Evrim Doğan, Fatma Keklik Karadağ, Demet Aydin, et al.
Expert Opinion on Pharmacotherapy
|
August 9, 2016
Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase
Guray Saydam, Ibrahim Celalettin Haznedaroglu, Leylagul Kaynar, et al.
Hematology (Amsterdam, Netherlands)
|
July 13, 2018
Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome-positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up
Guray Saydam, Ibrahim Celalettin Haznedaroglu, Leylagul Kaynar, et al.
Hematology (Amsterdam, Netherlands)
|
March 1, 2018
Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase
Guray Saydam, Ibrahim C Haznedaroglu, Leylagul Kaynar, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 30, 2017
Outcomes of Chronic Myeloid Leukemia Patients With Early Molecular Response at 3 and 6 Months: A Comparative Analysis of Generic Imatinib and Glivec
Ahmet Emre Eskazan, Sevil Sadri, Dilek Keskin, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Plos One
|
October 24, 2025
Addressing multicollinearity in general linear model: A novel approach for ridge parameter with performance comparison
Muhammad Luqman, Sajjad Haider Bhatti, Demet Aydin, et al.
Scientific Reports
|
June 22, 2026
Hybrid analysis of photovoltaic energy data containing excessive structural zeros
Yasin Altinişik, Demet Aydin, Vedat Esen, et al.
Ocular Immunology and Inflammation
|
April 11, 2022
Orbital Mass as the Only Presenting Sign with Overlapping Features of Lupus Erythematosus Panniculitis and Subcutaneous Panniculitis-Like T-Cell Lymphoma
Mehmet Serhat Mangan, Ahmet Murat Sarici, Ozben Yalcin, et al.
Therapeutics and Clinical Risk Management
|
September 27, 2014
Bloodstream infections in patients with hematological malignancies: which is more fatal - cancer or resistant pathogens?
Habip Gedik, Funda Simşek, Arzu Kantürk, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|
May 2, 2022
Eltrombopag in the Treatment of Immune Thrombocytopenia: Two-Center Experience from Istanbul
Esma Evrim Dogan, Esra Turan Erkek, Tugrul Elverdi, et al.
Medicine
|
July 26, 2024
The assessment of health-related quality of life in patients with polycythemia vera
Esma Evrim Doğan, Fatma Keklik Karadağ, Demet Aydin, et al.
Expert Opinion on Pharmacotherapy
|
August 9, 2016
Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase
Guray Saydam, Ibrahim Celalettin Haznedaroglu, Leylagul Kaynar, et al.
Hematology (Amsterdam, Netherlands)
|
July 13, 2018
Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome-positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up
Guray Saydam, Ibrahim Celalettin Haznedaroglu, Leylagul Kaynar, et al.
Hematology (Amsterdam, Netherlands)
|
March 1, 2018
Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase
Guray Saydam, Ibrahim C Haznedaroglu, Leylagul Kaynar, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 30, 2017
Outcomes of Chronic Myeloid Leukemia Patients With Early Molecular Response at 3 and 6 Months: A Comparative Analysis of Generic Imatinib and Glivec
Ahmet Emre Eskazan, Sevil Sadri, Dilek Keskin, et al.
Page
of 1